AAAAAA
Results:
1-8
|
Results: 8
Authors:
Bousema, JT
Bussemakers, MJG
van Houwelingen, KP
Debruyne, FMJ
Verbeek, ALM
de la Rosette, JJMCH
Kiemeney, LA
Citation: Jt. Bousema et al., Polymorphisms in the vitamin D receptor gene and the androgen receptor gene and the risk of benign prostatic hyperplasia, EUR UROL, 37(2), 2000, pp. 234-238
Authors:
Verhaegh, GW
van Bokhoven, A
Smit, F
Schalken, JA
Bussemakers, MJG
Citation: Gw. Verhaegh et al., Isolation and characterization of the promoter of the human prostate cancer-specific DD3 gene, J BIOL CHEM, 275(48), 2000, pp. 37496-37503
Authors:
Bussemakers, MJG
Van Bokhoven, A
Tomita, K
Jansen, CFJ
Schalken, JA
Citation: Mjg. Bussemakers et al., Complex cadherin expression in human prostate cancer cells, INT J CANC, 85(3), 2000, pp. 446-450
Authors:
Tomita, K
van Bokhoven, A
van Leenders, GJLH
Ruijter, ETG
Jansen, CFJ
Bussemakers, MJG
Schalken, JA
Citation: K. Tomita et al., Cadherin switching in human prostate cancer progression, CANCER RES, 60(13), 2000, pp. 3650-3654
Authors:
Tomita, K
van Bokhoven, A
Jansen, CFJ
Bussemakers, MJG
Schalken, JA
Citation: K. Tomita et al., Coordinate recruitment of E-cadherin and ALCAM to cell-cell contacts by alpha-catenin, BIOC BIOP R, 267(3), 2000, pp. 870-874
Authors:
Bussemakers, MJG
Citation: Mjg. Bussemakers, Changes in gene expression and targets for therapy, EUR UROL, 35(5-6), 1999, pp. 408-412
Authors:
Ruijter, ETG
Miller, GJ
Van de Kaa, CA
Van Bokhoven, A
Bussemakers, MJG
Debruyne, FMJ
Ruiter, DJ
Schalken, JA
Citation: Etg. Ruijter et al., Molecular analysis of multifocal prostate cancer lesions, J PATHOLOGY, 188(3), 1999, pp. 271-277
Authors:
Bussemakers, MJG
van Bokhoven, A
Verhaegh, GW
Smit, FP
Karthaus, HFM
Schalken, JA
Debruyne, FMJ
Ru, N
Issacs, WB
Citation: Mjg. Bussemakers et al., DD3: A new prostate-specific gene, highly overexpressed in prostate cancer, CANCER RES, 59(23), 1999, pp. 5975-5979
Risultati:
1-8
|